This award will recognize individual AAPP member efforts and accomplishments in increasing patient access to high quality mental health care in exceptional and distinctive ways. This may include activities that increase access to psychiatric pharmacist-led interprofessional care. Examples include reduction and/or mitigation of social determinants of health for people living with mental illness, increased access to novel treatments and/or clinical interventions through research, etc. Activities and projects must demonstrate impact on patient care to be considered for this award. Award candidates must also demonstrate how these activities and accomplishments go beyond the confines/standard expectations of their employment and how they led or substantially contributed to the activity(ies).
Criteria
- Nominee has been an AAPP member for at least 3 of the past 5 years preceding submission for the award, including the current year of the submission.
- Board certification as a Board-Certified Psychiatric Pharmacist (BCPP) is not required but will be weighted in award scoring.
- Applications should only be submitted for nominees who have developed and led patient mental health care programs or efforts that exceed the usual/standard expectations of a psychiatric pharmacist or their job role.
- This award is intended to recognize an individual AAPP member leading a program, effort, or activity that involves or involved 2 or more of the following:
- Interprofessional collaboration to advance the care of persons with mental illness, particularly increasing access to care.
- Resource development leading to increased sustainable access to high quality mental health care for patients (e.g., patient assistance programs or other mechanisms).
- Design and implementation of unique delivery methods to provide mental health care in communities without reliable access to care (e.g., rural, disadvantaged, etc. communities).
- Creation and implementation of mechanisms to proactively limit impact of social determinants of health on people living with mental illness.
- Development and rollout of programs to increase access to novel psychotherapeutic treatments for persons with mental illness.
- The conduct of research that supports the model of care increasing access to high quality mental health care, particularly involving a psychiatric pharmacist.
- The program must have been initiated within the preceding five (5) years of submitting for the award.
- The program, effort, or activity must have resulted in impact at the local, state, or national level with demonstrated outcomes, as described in a publication or through other public dissemination (posters, presentations, etc.) of the program.
Applicant Materials
This award is intended to recognize psychiatric pharmacists working in the field of mental health care which is inclusive of substance use disorders. Nominations for this awards can be made by the applicant themselves or an individual(s) who wishes to nominate and submit the required elements for consideration by the committee. Judith J. Saklad Memorial Award recipients are not eligible for consideration of any other AAPP Awards given that the Saklad Award is a pinnacle award and broadly encompasses the various components of other AAPP awards.
Materials required to be submitted include:
- CV
- Cover Letter: Describing how the effort or activity meets or exceeds the above criteria as well as how the nominee, led, significantly impacted, or enabled the initiative/activity and the realized outcomes. The letter should also specifically address criteria 3, 4, and 5 above, and introduce the relevance of the publication(s) or other scholarly work(s) required for criteria 6. Information on the total number of patients impacted by the program, as well as degree of that impact should be described. Listing of related publication(s) or supporting poster(s) should be included. Publication(s) and other supporting scholarship directly related to the effort/activity must be from within the previous three (3) years. The cover letter should not exceed four (4) single spaced pages.
- Letter of Support: From a colleague or team member with direct visibility into the quality, uniqueness, and impact of the activity, program, or initiative being nominated as well as the leadership of the psychiatric pharmacist applying for the award. The letter should not exceed 3 pages single spaced and should specifically address how the program and the pharmacist nominated meet criteria 3 and 4 above.
